Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended Indication for Primary Prevention of Cardiovascular Disease in Cardiology Practices: Insights From the NCDR PINNACLE Registry.
Ravi S HiraKensey L GoschDhruv S KaziRobert W YehAkash KatarukaThomas M MaddoxTina ShahHani JneidDeepak L BhattSalim S ViraniPublished in: Circulation. Cardiovascular quality and outcomes (2022)
Immediately before the 2019 American College of Cardiology/American Heart Association Guidelines on Primary Prevention of Cardiovascular Disease, over one-fourth of patients in this national registry were receiving aspirin for primary prevention inappropriately or without a recommended indication with significant practice-level variation. These findings help to determine the potential impact of guideline recommendations on contemporary use of aspirin for primary prevention.
Keyphrases
- cardiovascular disease
- cardiovascular events
- low dose
- clinical practice
- antiplatelet therapy
- primary care
- healthcare
- end stage renal disease
- type diabetes
- newly diagnosed
- ejection fraction
- cardiovascular risk factors
- anti inflammatory drugs
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- cardiac surgery
- coronary artery disease
- human health
- percutaneous coronary intervention
- climate change
- patient reported outcomes